Monocyte chemoattractant protein‐1 predicts the development of diabetic nephropathy
Diabetes/Metabolism Research and Reviews2021Vol. 38(2), pp. e3497–e3497
Citations Over TimeTop 10% of 2021 papers
Florian G. Scurt, Jan Menne, Sabine Brandt, Anja Bernhardt, Peter R. Mertens, Hermann Haller, Christos Chatzikyrkou
Abstract
MCP-1 is a marker and possibly a mediator of early diabetic nephropathy. Further prospective studies are necessary to test whether diabetic patients with elevated MCP-1 levels would benefit from specific therapeutic interventions.
Related Papers
- Microalbuminuria, is it so important?(2007)
- → A study of predictive value of microalbuminuria in early outcome of non-diabetic patients of acute myocardial infarction(2017)2 cited
- Clinical study of ischemia heart disease and microalbuminuria in subjects with type II diabetes mellitus(2001)
- [Microalbuminuria in diabetics. II--Methodological aspects and therapeutic perspectives].(1987)
- Microalbuminuria : from epidemiology to clinical management(1998)